Shereen Keleg

1.1k total citations
20 papers, 917 citations indexed

About

Shereen Keleg is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shereen Keleg has authored 20 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Shereen Keleg's work include Pancreatic and Hepatic Oncology Research (12 papers), Hedgehog Signaling Pathway Studies (9 papers) and Epigenetics and DNA Methylation (4 papers). Shereen Keleg is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Hedgehog Signaling Pathway Studies (9 papers) and Epigenetics and DNA Methylation (4 papers). Shereen Keleg collaborates with scholars based in Germany, United States and France. Shereen Keleg's co-authors include Markus W. Büchler, Jörg Kleeff, Hany Kayed, Helmut Frieß, Thomas Giese, Helmut Friess, Peter Büchler, Roman Ludwig, Iréne Esposito and Nathalia A. Giese and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Shereen Keleg

20 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shereen Keleg Germany 16 581 463 184 115 76 20 917
Esther S.Y. Wong Hong Kong 15 749 1.3× 345 0.7× 190 1.0× 68 0.6× 85 1.1× 20 1.0k
Juliet G. Carbon United States 15 412 0.7× 357 0.8× 167 0.9× 73 0.6× 55 0.7× 18 962
Demirkan Gursel United States 19 491 0.8× 270 0.6× 284 1.5× 125 1.1× 64 0.8× 32 970
Claire B. Pollock United States 8 484 0.8× 308 0.7× 115 0.6× 74 0.6× 82 1.1× 10 815
Paraskevi Alexandrou Greece 18 497 0.9× 390 0.8× 280 1.5× 49 0.4× 72 0.9× 43 922
Jane D. Holland Germany 10 879 1.5× 569 1.2× 244 1.3× 61 0.5× 100 1.3× 11 1.3k
S. Streit Germany 7 481 0.8× 364 0.8× 130 0.7× 47 0.4× 63 0.8× 8 823
Vijayalakshmi Kari Germany 19 837 1.4× 425 0.9× 218 1.2× 62 0.5× 57 0.8× 21 1.1k
Teruyuki Muraguchi Japan 11 748 1.3× 326 0.7× 235 1.3× 49 0.4× 77 1.0× 11 1.2k
Alexander Gheldof Belgium 11 660 1.1× 437 0.9× 285 1.5× 70 0.6× 140 1.8× 26 1.1k

Countries citing papers authored by Shereen Keleg

Since Specialization
Citations

This map shows the geographic impact of Shereen Keleg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen Keleg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen Keleg more than expected).

Fields of papers citing papers by Shereen Keleg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shereen Keleg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen Keleg. The network helps show where Shereen Keleg may publish in the future.

Co-authorship network of co-authors of Shereen Keleg

This figure shows the co-authorship network connecting the top 25 collaborators of Shereen Keleg. A scholar is included among the top collaborators of Shereen Keleg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shereen Keleg. Shereen Keleg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keleg, Shereen, Anette Heller, Thomas Giese, et al.. (2014). Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors. PLoS ONE. 9(6). e100178–e100178. 22 indexed citations
2.
Fredebohm, Johannes, Michael Boettcher, Christian Eisen, et al.. (2012). Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System. PLoS ONE. 7(11). e48503–e48503. 37 indexed citations
3.
Welsch, Thilo, Stefanie Zschäbitz, Verena Becker, et al.. (2011). Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma. PLoS ONE. 6(8). e23151–e23151. 9 indexed citations
4.
Welsch, Thilo, et al.. (2009). Actinin-4 Expression in Primary and Metastasized Pancreatic Ductal Adenocarcinoma. Pancreas. 38(8). 968–976. 39 indexed citations
5.
Welsch, Thilo, Shereen Keleg, Frank Bergmann, et al.. (2009). Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Clinical & Experimental Metastasis. 26(7). 701–711. 16 indexed citations
6.
Kayed, Hany, Shereen Keleg, Thilo Welsch, et al.. (2008). Expression of the Shwachman-Bodian-Diamond syndrome (SBDS) protein in human pancreatic cancer and chronic pancreatitis.. PubMed. 23(7). 819–26. 4 indexed citations
7.
Kayed, Hany, Shereen Keleg, Christoph Michalski, et al.. (2007). BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Molecular Cancer. 6(1). 83–83. 22 indexed citations
8.
Kayed, Hany, Xiaojie Jiang, Shereen Keleg, et al.. (2007). Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. British Journal of Cancer. 97(8). 1106–1115. 58 indexed citations
9.
Esposito, Iréne, Hany Kayed, Shereen Keleg, et al.. (2007). Tumor-Suppressor Function of SPARC-Like Protein 1/Hevin in Pancreatic Cancer. Neoplasia. 9(1). 8–17. 71 indexed citations
10.
Keleg, Shereen, Hany Kayed, Xiaohua Jiang, et al.. (2007). Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. International Journal of Cancer. 121(1). 21–32. 79 indexed citations
11.
Kayed, Hany, et al.. (2006). Hedgehog Signaling in the Normal and Diseased Pancreas. Pancreas. 32(2). 119–129. 59 indexed citations
12.
Kayed, Hany, Jörg Kleeff, Shereen Keleg, et al.. (2006). Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Letters. 245(1-2). 171–183. 13 indexed citations
13.
Shrikhande, Shailesh V., Jörg Kleeff, Hany Kayed, et al.. (2006). Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.. PubMed. 26(5A). 3265–73. 47 indexed citations
14.
Kayed, Hany, Jörg Kleeff, Shereen Keleg, et al.. (2006). Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma. International Journal of Oncology. 36 indexed citations
15.
Kayed, Hany, Jörg Kleeff, Armin Kolb, et al.. (2005). FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. International Journal of Cancer. 118(1). 43–54. 58 indexed citations
16.
Kayed, Hany, Jörg Kleeff, Iréne Esposito, et al.. (2005). Localization of the human hedgehog‐interacting protein (Hip) in the normal and diseased pancreas. Molecular Carcinogenesis. 42(4). 183–192. 26 indexed citations
17.
Kayed, Hany, Jörg Kleeff, Shereen Keleg, et al.. (2004). Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer. International Journal of Cancer. 110(5). 668–676. 95 indexed citations
18.
Kleeff, Jörg, Hany Kayed, Shereen Keleg, et al.. (2004). LOCALIZATION OF THE HUMAN HEDGEHOG-INTERACTING PROTEIN (HIP) IN THE NORMAL AND DISEASED PANCREAS.. Pancreas. 29(4). 327–327. 2 indexed citations
19.
Kayed, Hany, et al.. (2003). Distribution of Indian hedgehog and its receptors patched and smoothened in human chronic pancreatitis. Journal of Endocrinology. 178(3). 467–478. 44 indexed citations
20.
Keleg, Shereen, Peter Büchler, Roman Ludwig, Markus W. Büchler, & Helmut Frieß. (2003). Invasion and metastasis in pancreatic cancer.. Molecular Cancer. 2(1). 14–14. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther S.Y. Wong Breakdown of academic impact, for papers by Juliet G. Carbon Breakdown of academic impact, for papers by Demirkan Gursel Breakdown of academic impact, for papers by Claire B. Pollock Breakdown of academic impact, for papers by Paraskevi Alexandrou Breakdown of academic impact, for papers by Jane D. Holland Breakdown of academic impact, for papers by S. Streit Breakdown of academic impact, for papers by Vijayalakshmi Kari Breakdown of academic impact, for papers by Teruyuki Muraguchi Breakdown of academic impact, for papers by Alexander Gheldof
Rankless by CCL
2026